1. Combining monoamine oxidase B and semicarbazide-sensitive amine oxidase enzyme inhibition to address inflammatory disease. (15th October 2022) Authors: Foot, Jonathan S.; Buson, Alberto; Deodhar, Mandar; Findlay, Alison D.; Robertson, Alan D.; Turner, Craig I.; Yow, Tin; Zhou, Wenbin; Jarolimek, Wolfgang Journal: Bioorganic & medicinal chemistry letters Issue: Volume 74(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Inhibition of semicarbazide‐sensitive amine oxidase/vascular adhesion protein‐1 reduces lipopolysaccharide‐induced neuroinflammation. (10th June 2017) Authors: Becchi, Serena; Buson, Alberto; Foot, Jonathan; Jarolimek, Wolfgang; Balleine, Bernard W Journal: British journal of pharmacology Issue: Volume 174:Number 14(2017) Page Start: 2302 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The lysyl oxidase like 2/3 enzymatic inhibitor, PXS‐5153A, reduces crosslinks and ameliorates fibrosis. Issue 3 (9th December 2018) Authors: Schilter, Heidi; Findlay, Alison D.; Perryman, Lara; Yow, Tin T.; Moses, Joshua; Zahoor, Amna; Turner, Craig I.; Deodhar, Mandar; Foot, Jonathan S.; Zhou, Wenbin; Greco, Angelique; Joshi, Amar; Rayner, Benjamin; Townsend, Sarah; Buson, Alberto; Jarolimek, Wolfgang Journal: Journal of cellular and molecular medicine Issue: Volume 23:Issue 3(2019) Page Start: 1759 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗